Consun Pharmaceutical Group's H1 Profit Jumps 25%

MT Newswires Live
2025/08/19

Consun Pharmaceutical Group (HKG:1681) booked 498.3 million yuan in attributable profit in the first half of 2025, rising 25% from 399.8 million yuan a year earlier, according to a Hong Kong bourse filing Tuesday.

Earnings per share were 0.58 yuan, compared with 0.49 yuan in the prior year.

Revenue rose 24% year on year to 1.57 billion yuan, figures showed.

The company announced a dividend of HK$0.33 per share, payable Sept. 19 to shareholders of record on Sept. 5.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10